- Home
- RNGR vs KALV Comparison
RNGR vs KALV Comparison
Compare RNGR & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNGR
- KALV
- Stock Information
- Founded
- RNGR 2017
- KALV N/A
- Country
- RNGR United States
- KALV United States
- Employees
- RNGR N/A
- KALV N/A
- Industry
- RNGR Oilfield Services/Equipment
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- RNGR Energy
- KALV Health Care
- Exchange
- RNGR Nasdaq
- KALV Nasdaq
- Market Cap
- RNGR 388.4M
- KALV 362.2M
- IPO Year
- RNGR 2017
- KALV N/A
- Fundamental
- Price
- RNGR $17.42
- KALV $10.03
- Analyst Decision
- RNGR Hold
- KALV Strong Buy
- Analyst Count
- RNGR 2
- KALV 8
- Target Price
- RNGR $12.50
- KALV $25.67
- AVG Volume (30 Days)
- RNGR 92.6K
- KALV 334.3K
- Earning Date
- RNGR 03-03-2025
- KALV 03-10-2025
- Dividend Yield
- RNGR 1.15%
- KALV N/A
- EPS Growth
- RNGR N/A
- KALV N/A
- EPS
- RNGR 0.63
- KALV N/A
- Revenue
- RNGR $579,500,000.00
- KALV N/A
- Revenue This Year
- RNGR N/A
- KALV N/A
- Revenue Next Year
- RNGR $12.00
- KALV N/A
- P/E Ratio
- RNGR $27.63
- KALV N/A
- Revenue Growth
- RNGR N/A
- KALV N/A
- 52 Week Low
- RNGR $9.27
- KALV $7.30
- 52 Week High
- RNGR $18.45
- KALV $15.50
- Technical
- Relative Strength Index (RSI)
- RNGR 54.07
- KALV 59.09
- Support Level
- RNGR $17.08
- KALV $8.99
- Resistance Level
- RNGR $18.45
- KALV $11.00
- Average True Range (ATR)
- RNGR 0.52
- KALV 0.57
- MACD
- RNGR 0.02
- KALV 0.11
- Stochastic Oscillator
- RNGR 58.52
- KALV 57.08
About RNGR Ranger Energy Services Inc.
Ranger Energy Services Inc is a provider of onshore high specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions and Ancillary Services, of which key revenue is derived from High Specification Rigs segment.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.